SynthesisFrontiers in immunology2025

Role of tumor mutational burden in patients with urothelial carcinoma treated with immune checkpoint inhibitors: a systematic review and meta-analysis.

Zhe Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.